​Greg Warzecha is a Polish entrepreneur and deep learning expert with over a decade of experience in artificial intelligence (AI). He is the founder and CEO of Genotic, a biotechnology startup that leverages AI to revolutionize antibody development. Genotic's platform utilizes advanced deep learning algorithms to identify new antibodies faster than traditional methods, and with guaranteed high specificity. This approach enables rapid development of targeted antibodies for various applications. Prior to establishing Genotic, Warzecha co-founded User.com, a marketing automation platform. Under his leadership, User.com expanded its services to over 340 clients, including brands such as Carrefour, BNP Paribas, and LG Electronics. The platform's success culminated in its acquisition in 2023, underscoring Warzecha's ability to scale technological solutions effectively.​​Greg Warzecha leverages his extensive experience in deep learning and AI to drive Genotic's innovative approach, demonstrating the transformative potential of AI in accelerating scientific development.​